Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

2008857 citationsJournal Article

Authors

Dominique Élias

Jérémie H. Lefèvre

Julie Chevalier

Antoine Brouquet

Frédéric Marchal · Centre de Recherche en Automatique de Nancy

Abstract

Patients with isolated, resectable PC achieve a median survival of 24 months with modern chemotherapies, but only surgical cytoreduction plus HIPEC is able to prolong median survival to roughly 63 months, with a 5-year survival rate of 51%.

Topics & Keywords

Intraperitoneal and Appendiceal Malignancies Appendicitis Diagnosis and Management Hernia repair and management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 27, Issue 5, pp. 681-685

DOI: 10.1200/jco.2008.19.7160

Field-Weighted Citation Impact: 28.82